← Open Payments lookup

TAM KANG: Open Payments

NPI 1407250442 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$648 in 32 payments from 13 companies in 2025. Trend: 2023 $462 · 2024 $577 · 2025 $648

Food & beverage: $648
CompanyPaymentsAmount
Astellas Pharma US Inc8$160
Lilly USA, LLC6$96
Sumitomo Pharma America, Inc.2$62
PFIZER INC.3$60
Janssen Pharmaceuticals, Inc2$53
Novo Nordisk Inc3$49
Exact Sciences Corporation2$44
SI-BONE, INC.1$28
GlaxoSmithKline, LLC.1$28
INOGEN, INC.1$24

Products named: Veozah, MOUNJARO, GEMTESA, PREVNAR 20, SPRAVATO, Wegovy, TRELEGY ELLIPTA, INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH.

Industry payments across TX — which companies pay providers there.